Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 4,963,800 | 3,263,201 | 5,658,000 | 5,824,300 | 5,228,300 |
| Cost of Goods | 1,164,600 | -58,200 | 1,586,300 | 1,571,700 | 1,347,900 |
| Gross Profit | 3,799,200 | 3,321,399 | 4,071,700 | 4,252,600 | 3,880,400 |
| Operating Expenses | 2,503,600 | 3,042,600 | 3,530,300 | 3,053,200 | 3,898,400 |
| Operating Income | 1,296,200 | 278,601 | 541,700 | 1,200,100 | -17,100 |
| Other Income | 69,500 | 112,900 | 49,900 | 60,400 | 78,300 |
| Pre-tax Income | 1,365,700 | 391,500 | 591,600 | 1,260,500 | 61,200 |
| Income Tax | 198,500 | 1,930,700 | 36,000 | 252,500 | 172,000 |
| Net Income Continuous | 1,167,200 | -1,539,200 | 555,600 | 1,008,000 | -110,800 |
| Net Income Discontinuous | 50,200 | N/A | N/A | N/A | N/A |
| Net Income | $1,217,400 | $-1,656,900 | $555,600 | $1,008,000 | $-110,800 |
| EPS Basic Total Ops | 1.16 | -1.58 | 0.53 | 0.96 | -0.10 |
| EPS Basic Continuous Ops | 1.11 | -1.46 | 0.53 | 0.96 | -0.10 |
| EPS Basic Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.16 | -1.57 | 0.53 | 0.95 | -0.10 |
| EPS Diluted Continuous Ops | 1.11 | -1.45 | 0.53 | 0.95 | -0.10 |
| EPS Diluted Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,719,000 | $690,501 | $914,600 | $1,595,700 | $369,800 |